1. Home
  2. BVS vs ESPR Comparison

BVS vs ESPR Comparison

Compare BVS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$10.68

Market Cap

617.1M

Sector

Health Care

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.12

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BVS
ESPR
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
617.1M
731.9M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
BVS
ESPR
Price
$10.68
$3.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
4
Target Price
$14.00
$8.75
AVG Volume (30 Days)
403.4K
14.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
163.46
60.71
EPS
0.33
N/A
Revenue
$568,087,000.00
$403,135,000.00
Revenue This Year
$7.52
N/A
Revenue Next Year
$7.06
$12.81
P/E Ratio
$30.65
N/A
Revenue Growth
N/A
21.31
52 Week Low
$5.81
$0.73
52 Week High
$10.76
$4.18

Technical Indicators

Market Signals
Indicator
BVS
ESPR
Relative Strength Index (RSI) 66.61 71.67
Support Level $8.43 $2.37
Resistance Level $10.76 $3.33
Average True Range (ATR) 0.43 0.11
MACD 0.02 0.16
Stochastic Oscillator 94.26 98.13

Price Performance

Historical Comparison
BVS
ESPR

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: